AUBREE TANT: Open Payments
NPI 1053841288 · HIRAM, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 19 payments from 12 companies in 2025. Trend: 2023 $247 · 2024 $431 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $69 |
| Amgen Inc. | 3 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| BIOTRONIK NRO, Inc. | 1 | $18 |
Products named: MOUNJARO, TZIELD, OTEZLA, LEQVIO, INSPIRE, Kerendia, Dexcom G6 Transmitter, UBRELVY.
Industry payments across GA — which companies pay providers there.
